Schedule 13G ownership disclosure
ADAPTIMMUNE THERAPEUTICS PLC
Security class unavailable · CUSIP: 00653A107
Event date: 2018-01-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,596,520
- Percent of class
- 1.8900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-18-006277
- Form type
- SC 13G
- Filer
- Adaptimmune Therapeutics PLC
- CIK
- CIK 1621227
- Filed
- Feb 02, 2018
- Reporting period
- Jan 31, 2018
- Description
- Schedule 13G beneficial ownership